Biomarker
Androgen receptor (AR) is a type of nuclear receptor that is activated by binding any of the androgenic hormones, including testosterone and dihydrotestosterone, in the cytoplasm and then translocating into the nucleus. Androgen deprivation therapy can suppress most prostate cancers.